Emerging Drugs in the Treatment of Inflammatory Bowel Disease: Beyond Anti-TNF-α
Author:
Affiliation:
1. Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea.
Publisher
The Korean Society of Gastroenterology
Subject
General Medicine
Link
https://synapse.koreamed.org/pdf/10.4166/kjg.2011.58.5.235
Reference82 articles.
1. Biologic therapy for inflammatory bowel disease
2. Biologic therapy of inflammatory bowel disease
3. New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis?
4. Inflammatory bowel disease: clinical aspects and established and evolving therapies
5. Tumor Necrosis Factor-Alpha Binding Capacity and Anti-Infliximab Antibodies Measured by Fluid-Phase Radioimmunoassays as Predictors of Clinical Efficacy of Infliximab in Crohn's Disease
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Alleviation of Intestinal Inflammation by Oral Supplementation of Unripe Apple Ethanolic Extract in Mice;Journal of the Korean Society of Food Science and Nutrition;2023-03-31
2. A Real-World Analysis of Prescribing Patterns and Non-persistence of Anti-TNFα Therapy for Inflammatory Bowel Disease;Clinical Drug Investigation;2019-05-16
3. Production of recombinant human interleukin-38 and its inhibitory effect on the expression of proinflammatory cytokines in THP-1 cells;Molecular Biology;2016-05
4. Natural Course of Crohn's Disease and Novel Treatment Drugs;Korean Journal of Medicine;2013
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3